Literature DB >> 1647268

Purification of B16-F1 melanoma autocrine motility factor and its receptor.

S Silletti1, H Watanabe, V Hogan, I R Nabi, A Raz.   

Abstract

Tumor autocrine motility factor (AMF) is a cytokine which stimulates both random and directed cell migration by self-producing cells. AMF has been detected in and purified from serum-free conditioned medium of murine B16-F1 melanoma cells. Under nonreducing conditions AMF migrates in sodium dodecyl sulfate-polyacrylamide gel electrophoresis as a single band of Mr 55,000, whereas under reducing conditions it migrates as a single polypeptide of Mr 64,000. Two-dimensional polyacrylamide gel electrophoresis of the purified AMF resolved two polypeptides with isoelectric points of 6.35 (major) and 6.4 (minor). No carbohydrate side chains were detected in the B16-F1 AMF. Purified AMF stimulated B16-F1 cell migration in a dose-dependent fashion and bound directly in a protein-protein-binding assay to the AMF receptor, a cell surface glycoprotein of Mr 78,000 [glycoprotein (gp) 78]. The involvement of gp78 in AMF-stimulated function was demonstrated by motility assays. These results suggest that AMF is the natural ligand for the gp78-AMF receptor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1647268

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

1.  Enzymatic function of multiple origins regulates the progression of colorectal cancer and the development of metastases.

Authors:  K A Paschos; D Canovas; N C Bird
Journal:  Hippokratia       Date:  2009-01       Impact factor: 0.471

2.  Identification and characterization of motility stimulating factor secreted from pancreatic cancer cells: role in tumor invasion and metastasis.

Authors:  Y Sakurai; T Sawada; Y S Chung; Y Funae; M Sowa
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

3.  Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells.

Authors:  S Silletti; S Paku; A Raz
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

Review 4.  Autocrine factors, type IV collagenase secretion and prostatic cancer cell invasion.

Authors:  M E Stearns; M Stearns
Journal:  Cancer Metastasis Rev       Date:  1993-03       Impact factor: 9.264

5.  Monoclonal antibodies against autocrine motility factor suppress gastric cancer.

Authors:  Hahn-Sun Jung; Su In Lee; Seung-Hoon Kang; Jin Sang Wang; Eun Hee Yang; Byungwook Jeon; Jayhyuk Myung; Ji Young Baek; Song-Kyu Park
Journal:  Oncol Lett       Date:  2017-04-13       Impact factor: 2.967

6.  Elevated expression of autocrine motility factor receptor correlates with overexpression of RhoC and indicates poor prognosis in hepatocellular carcinoma.

Authors:  Wei Wang; Lian-Yue Yang; Zhi-Li Yang; Ji-Xiang Peng; Jie-Quan Yang
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.199

7.  Differential purification of autocrine motility factor derived from a murine protein-free fibrosarcoma.

Authors:  H Watanabe; K Kanbe; M Chigira
Journal:  Clin Exp Metastasis       Date:  1994-03       Impact factor: 5.150

8.  Platelet-derived growth factor (PDGF) BB acts as a chemoattractant for human malignant mesothelioma cells via PDGF receptor beta-integrin alpha3beta1 interaction.

Authors:  J Klominek; B Baskin; D Hauzenberger
Journal:  Clin Exp Metastasis       Date:  1998-08       Impact factor: 5.150

9.  Tumor cell motility and metastasis : Autocrine motility factor as an example of ecto/exoenzyme cytokines.

Authors:  S Silletti; S Paku; A Raz
Journal:  Pathol Oncol Res       Date:  1997-09       Impact factor: 3.201

Review 10.  Autocrine motility factor and its receptor: role in cell locomotion and metastasis.

Authors:  I R Nabi; H Watanabe; A Raz
Journal:  Cancer Metastasis Rev       Date:  1992-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.